Literature DB >> 19481284

'Microalbuminuric anaemia'--the relationship between haemoglobin levels and albuminuria in diabetes.

O R Adetunji1, H Mani, A Olujohungbe, K A Abraham, G V Gill.   

Abstract

BACKGROUND: There is an increasing incidence of anaemia in diabetes despite the absence of significant renal impairment. AIMS: This study set out to determine the prevalence of anaemia in a diabetic population and to explore the relationship between anaemia and urinary albumin excretion in diabetes mellitus. Also, to determine the difference between those with overt nephropathy, microalbuminuria and those without evidence of renal disease.
METHODS: Five hundred and two consecutive diabetes patients were screened for anaemia. Anaemia was defined by World Health Organization criteria (<13 g/dl for men and <12 g/dl for women). Urinary albumin excretion was determined by urinary albumin creatinine ratio (ACR) from a single urine sample.
RESULTS: Anaemia was present in 118 (23.5%) patients. There was a rise in the prevalence of anaemia from 19% in patients with a normal ACR to 29% in those with microalbuminuria and to 41% in macroalbuminuria. This increase in the prevalence of anaemia in microalbuminuria compared to normoalbuminuria was not explained by declining renal function as there was no significant difference in eGFR between the two groups.
CONCLUSION: Anaemia was common in the study population. Early detection and correction of anaemia in diabetes is important for patients at risk of impaired quality of life and increased cardiovascular risk.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19481284     DOI: 10.1016/j.diabres.2009.04.028

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  7 in total

1.  Prevalence of kidney disease in anaemia differs by GFR-estimating method: the Third National Health and Nutrition Examination Survey (1988-94).

Authors:  Michelle M Estrella; Brad C Astor; Anna Köttgen; Elizabeth Selvin; Josef Coresh; Rulan S Parekh
Journal:  Nephrol Dial Transplant       Date:  2010-02-22       Impact factor: 5.992

2.  Associations between hemoglobin concentrations and the clinical characteristics of patients with type 2 diabetes.

Authors:  Jin Ook Chung; Dong Hyeok Cho; Dong Jin Chung; Min Young Chung
Journal:  Korean J Intern Med       Date:  2012-09-01       Impact factor: 2.884

3.  Albuminuria as a Risk Factor for Anemia in Chronic Kidney Disease: Result from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD).

Authors:  Ji Suk Han; Mi Jung Lee; Kyoung Sook Park; Seung Hyeok Han; Tae-Hyun Yoo; Kook-Hwan Oh; Sue Kyung Park; Joongyub Lee; Young Youl Hyun; Wookyung Chung; Yeong Hoon Kim; Curie Ahn; Kyu Hun Choi
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

4.  Mild anemia is frequent and associated with micro- and macroangiopathies in patients with type 2 diabetes mellitus.

Authors:  Hiroyuki Ito; Yuichiro Takeuchi; Hidenori Ishida; Aya Otawa; Akane Shibayama; Shinichi Antoku; Mariko Abe; Mizuo Mifune; Michiko Togane
Journal:  J Diabetes Investig       Date:  2010-12-03       Impact factor: 4.232

5.  Soluble α-klotho as a novel biomarker in the early stage of nephropathy in patients with type 2 diabetes.

Authors:  Eun Young Lee; Sang Soo Kim; Ji-Sung Lee; In Joo Kim; Sang Heon Song; Seung-Kuy Cha; Kyu-Sang Park; Jeong Suk Kang; Choon Hee Chung
Journal:  PLoS One       Date:  2014-08-01       Impact factor: 3.240

6.  Hemoglobin, Albuminuria, and Kidney Function in Cardiovascular Risk: The ARIC (Atherosclerosis Risk in Communities) Study.

Authors:  Junichi Ishigami; Morgan E Grams; Rakhi P Naik; Melissa C Caughey; Laura R Loehr; Shinichi Uchida; Josef Coresh; Kunihiro Matsushita
Journal:  J Am Heart Assoc       Date:  2018-01-12       Impact factor: 5.501

7.  Prevalence of anemia in diabetic adult outpatients in Northeast Ethiopia.

Authors:  Temesgen Fiseha; Aderaw Adamu; Melkam Tesfaye; Angesom Gebreweld
Journal:  PLoS One       Date:  2019-09-09       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.